Spanish Society of Pulmonology and Thoracic Surgery COVID-19 Patient Registry (RECOVID)

The world is experiencing the consequences of a pandemic caused by the SARS-CoV-2 coronavirus: our public healthcare system has collapsed, our economy has come to a standstill, and our country, along with one-third of the global population, has been confined.

One of the most striking aspects from a scientific standpoint is the limited knowledge we have about both the virus and the disease it causes, as well as its treatment and potential consequences. The approach to how we act, diagnose, and treat varies day by day based on healthcare availability and the limited evidence emerging from other countries in similar situations or those that have already overcome the worst and are analyzing their collected data. Particularly from a therapeutic perspective, much of the treatment effectiveness remains unknown.

While numerous clinical trials are underway to address some of the therapeutic questions, it is essential to systematically collect both cross-sectional and longitudinal data and experiences that we are accumulating, as other countries are doing. In addition to the need to understand patient characteristics, it is very likely that both risk factors and treatment response may differ depending on the geographic region of the patients

SEPAR has accumulated extensive experience in the development, maintenance, and utilization of large patient registries, some of which are globally recognized. Other specialized societies in our country are already tracking COVID-19 patients and establishing their own databases (Microbiology, Internal Medicine). Pulmonology is playing a crucial role in this epidemic, and SEPAR cannot remain on the sidelines.

In May 2020, SEPAR initiated a national registry of COVID-19 patients (RECOVID), both cross-sectional and longitudinal, with the goal of aiding in understanding the epidemiology, risk factors, diagnosis, therapeutic response, and patient outcomes. It also serves as a database for SEPAR’s areas to conduct research projects.

Collaboration agreement with:

Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) as the promoter of the National Registry RECOVID.